FTH earnings date and last-quarter result: last quarter miss, P/E -0.19. Updated 2026-07-23.
Faeth Therapeutics (FTH) Research Hub
Faeth Therapeutics (FTH) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 16.83 USD (-1.46%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.19, market cap 0.04B. This hub links to the full technical, earnings and options research available for FTH.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 16.83 USD (-1.46%) |
| 52-week range | 13.76 USD – 42.14 USD |
| Trend regime | Range |
| 14-day RSI | 21.2 (Oversold) |
| Trailing P/E | -0.19 |
| Market cap | 0.04B |
| Dividend yield | 0.00% |
Available research for FTH
Covered Call on FTH: how it works, illustrative setup around the real 16.83 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on FTH: how it works, illustrative setup around the real 16.83 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on FTH: how it works, illustrative setup around the real 16.83 USD price, max profit/loss, breakeven and when to use it. Educational.
FTH technical analysis: range, last 16.83 USD, RSI 21.2, 52w range 13.76 USD–42.14 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is FTH in?
Faeth Therapeutics (FTH) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is FTH in an uptrend or downtrend?
As of 2026-10-26, FTH is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is FTH's trailing P/E ratio?
FTH's trailing P/E is -0.19, with a market cap of 0.04B. See the earnings research page for full valuation detail.